Search results for "MICE"

showing 10 items of 6027 documents

Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects.

2012

Up-regulation of the folding machinery of the heat-shock protein 90 (Hsp90) chaperone protein is crucial for cancer progression. The two Hsp90 isoforms (α and β) play different roles in response to chemotherapy. To identify isoform-selective inhibitors of Hsp90(α/β)/cochaperone p23 interactions, we developed a dual-luciferase (Renilla and Firefly) reporter system for high-throughput screening (HTS) and monitoring the efficacy of Hsp90 inhibitors in cell culture and live mice. HTS of a 30,176 small-molecule chemical library in cell culture identified a compound, N -(5-methylisoxazol-3-yl)-2-[4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio]acetamide (CP9), that binds to Hsp90(α/β) an…

Thymidine kinase activityProtein FoldingImmunoprecipitationLactams MacrocyclicBlotting WesternMice NudeThiophenesBiologyThioacetamideTritiumSmall Molecule LibrariesMiceco-chaperone p23Luciferases FireflyHeat shock proteinCell Line TumorNeoplasmsAcetamidesDrug DiscoveryBenzoquinonesAnimalsHumansImmunoprecipitationProtein IsoformsLuciferaseHSP90 Heat-Shock ProteinsLuciferases RenillaProstaglandin-E SynthasesMultidisciplinaryCell growthImidazolesbioluminescence imagingHsp90Small moleculeMolecular biologydrug developmentHigh-Throughput Screening Assayssmall-molecule inhibitorsIntramolecular OxidoreductasesLeadPNAS PlusCell culturePositron-Emission TomographyPyrazinesbiology.proteinPET/computed tomography imagingTomography X-Ray ComputedProceedings of the National Academy of Sciences of the United States of America
researchProduct

Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage.

2011

BACKGROUND: Tight-junction (TJ) protein degradation is a decisive step in hypoxic blood-brain barrier (BBB) breakdown in stroke. In this study we elucidated the impact of acute cerebral ischemia on TJ protein arrangement and the role of the apoptotic effector protease caspase-3 in this context. METHODOLOGY/PRINCIPAL FINDINGS: We used an in vitro model of the neurovascular unit and the guinea pig whole brain preparation to analyze with immunohistochemical methods the BBB properties and neurovascular integrity. In both methodological approaches we observed rapid TJ protein disruptions after 30 min of oxygen and glucose deprivation or middle cerebral artery occlusion, which were accompanied by…

Time FactorsAnatomy and Physiologylcsh:MedicineMiceMolecular Cell BiologyPathologySignaling in Cellular ProcessesHypoxia Brainlcsh:ScienceCells CulturedNeuropathologyApoptotic SignalingMultidisciplinaryTight junctionCaspase 3ChemistryAnimal ModelsCell biologyTransport proteinProtein Transportmedicine.anatomical_structureNeurologyBlood-Brain BarrierMedicineResearch ArticleSignal TransductionClinical Research DesignCerebrovascular DiseasesGuinea PigsIschemiaContext (language use)Caspase 3Protein degradationBlood–brain barrierNeurological SystemTight JunctionsCapillary PermeabilityModel OrganismsDiagnostic MedicinemedicineAnimalsTransient Ischemic AttacksAnimal Models of DiseaseClaudinBiologyIschemic Strokelcsh:REndothelial CellsMembrane ProteinsPhosphoproteinsmedicine.diseaseAnatomical PathologyClaudinsImmunologyZonula Occludens-1 ProteinNervous System Componentslcsh:QPLoS ONE
researchProduct

Time-Lapse Dynamics of the Mouse Oocyte Chromatin Organisation during Meiotic Resumption

2014

In the mammalian oocyte, distinct patterns of centromeres and pericentromeric heterochromatin localisation correlate with the gamete’s developmental competence. Mouse antral oocytes display two main types of chromatin organisation: SN oocytes, with a ring of Hoechst-positive chromatin surrounding the nucleolus, and NSN oocytes lacking this ring. When matured to MII and fertilised, only SN oocytes develop beyond the 2-cell, and reach full term. To give detailed information on the dynamics of the SN or NSN chromatin during meiosis resumption, we performed a 9 hr time-lapse observation. The main significant differences recorded are: (1) reduction of the nuclear area only in SN oocytes; (2) ~17…

Time FactorsArticle SubjectNucleoluslcsh:MedicinePerivitelline spaceBiologyTime-Lapse ImagingGeneral Biochemistry Genetics and Molecular BiologyMiceProphaseMeiosisCentromeremedicineAnimalsCells CulturedGeneticsGeneral Immunology and Microbiologylcsh:RGeneral MedicineOocyteChromatinCell biologyChromatinMeiosismedicine.anatomical_structureOocytesGameteFemaleResearch ArticleBioMed Research International
researchProduct

Expression and possible functions of the cholinergic system in a murine embryonic stem cell line.

2007

The expression of a cholinergic system during embryonic development is a widespread phenomenon. However, no precise function could be assigned to it during early pre-neural stages and there are only few studies that document when it precisely starts to be expressed. Here, we examined the expression of cholinergic components in a murine embryonic stem cell line by RT-PCR, histochemistry, and enzyme activity measurements; the acetylcholine (ACh) content was measured by HPLC. We have demonstrated that embryonic stem cells express ACh, acetylcholine receptors, choline acetyltransferase (ChAT), acetyl- and butyryl-cholinesterase (AChE and BChE). Butyryl-cholinesterase (BChE) expression was highe…

Time FactorsBiologyGeneral Biochemistry Genetics and Molecular BiologyCell LineCholine O-AcetyltransferaseMicemedicineAnimalsCholinesterasesReceptors CholinergicGeneral Pharmacology Toxicology and PharmaceuticsEmbryonic Stem CellsAcetylcholine receptorCell ProliferationTetraisopropylpyrophosphamideReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingGeneral MedicineBenzenaminium 44'-(3-oxo-15-pentanediyl)bis(NN-dimethyl-N-2-propenyl-) DibromideCholine acetyltransferaseEmbryonic stem cellMolecular biologyAcetylcholineCell cultureButyrylcholinesteraseAcetylcholinesteraseCholinergicCholinesterase InhibitorsStem cellAcetylcholineAdult stem cellmedicine.drugLife sciences
researchProduct

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

2004

The cytokine erythropoietin (Epo) is tissue-protective in preclinical models of ischemic, traumatic, toxic, and inflammatory injuries. We have recently characterized Epo derivatives that do not bind to the Epo receptor (EpoR) yet are tissue-protective. For example, carbamylated Epo (CEpo) does not stimulate erythropoiesis, yet it prevents tissue injury in a wide variety ofin vivoandin vitromodels. These observations suggest that another receptor is responsible for the tissue-protective actions of Epo. Notably, prior investigation suggests that EpoR physically interacts with the common β receptor (βcR), the signal-transducing subunit shared by the granulocyte-macrophage colony stimulating fa…

Time FactorsBiologyMotor ActivityHeteroreceptorNeuroprotectionCell LineMicemedicineReceptors ErythropoietinAnimalsVentricular Functionerythropoietin receptor; common beta receptor; tissue injury; CytokinesReceptorErythropoietinAortaCells CulturedSpinal Cord InjuriesMice KnockoutMultidisciplinaryCell MembraneBiological SciencesErythropoietin Erythropoietin receptor neuroprotectionErythropoietin receptorCell biologyMice Inbred C57BLProtein SubunitsErythrocyte maturationErythropoietinKnockout mouseImmunologyErythropoiesismedicine.drug
researchProduct

Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation.

2000

Many in vitro studies have used cell cultures to focus on the relationships between cyclo-oxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) isoforms. We have investigated the time-course of regulation and the role of COX-2 and iNOS in a model of experimental inflammation in mice, the air pouch injected with zymosan. This study demonstrates that there is an early acute phase (4 h) mediated mainly by eicosanoids, with high levels of prostaglandin E2 (PGE2) produced by cyclo-oxygenase-1. In addition, in the later phase (from 12 h) there is a participation of nitric oxide (NO) and PGE2 accompanied by co-induction of both iNOS and COX-2. These enzymes were detected in migrating leuk…

Time FactorsBlotting WesternAnti-Inflammatory AgentsFluorescent Antibody TechniqueNitric Oxide Synthase Type IIInflammationPharmacologyDexamethasoneDinoprostoneNitric oxidechemistry.chemical_compoundMiceIn vivomedicineLeukocytesAnimalsCyclooxygenase InhibitorsProstaglandin E2NitritePharmacologyInflammationbiologyCyclooxygenase 2 InhibitorsZymosanZymosanGeneral MedicineExudates and TransudatesNitric oxide synthaseIsoenzymeschemistryBiochemistryCell cultureCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesEnzyme Inductionbiology.proteinEicosanoidsFemalemedicine.symptomNitric Oxide SynthaseColchicinemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin

2021

Nanoparticles (NPs) have emerged as a potential tool to improve cancer treatment. Among the proposed uses in imaging and therapy, their use as a drug delivery scaffold has been extensively highlighted. However, there are still some controversial points which need a deeper understanding before clinical application can occur. Here the use of gold nanoparticles (AuNPs) to detoxify the antitumoral agent cisplatin, linked to a nanoparticle via a pH-sensitive coordination bond for endosomal release, is presented. The NP conjugate design has important effects on pharmacokinetics, conjugate evolution and biodistribution and results in an absence of observed toxicity. Besides, AuNPs present unique o…

Time FactorsCancer TreatmentMetal Nanoparticleslcsh:MedicinePharmacologyMiceNanotechnologyTissue Distributionlcsh:Sciencemedia_commonDrug DistributionDrug CarriersMultidisciplinaryChemistryDNA NeoplasmOrgan SizeHydrogen-Ion ConcentrationEndocytosisOncologyColloidal goldDrug deliveryInactivation MetabolicMedicinemedicine.drugResearch ArticleBiotechnologyDrugBiodistributionDrugs and Devicesmedia_common.quotation_subjectMaterials ScienceAntineoplastic AgentsMaterial by AttributePharmacokineticsCell Line TumormedicineAnimalsHumansPharmacokineticsBiologyNanomaterialsCisplatinUnited States Food and Drug Administrationlcsh:RChemotherapy and Drug TreatmentUnited StatesBionanotechnologylcsh:QGoldNanocarriersCisplatinConjugate
researchProduct

Fluctuation Methods To Study Protein Aggregation in Live Cells: Concanavalin A Oligomers Formation

2011

Prefibrillar oligomers of proteins are suspected to be the primary pathogenic agents in several neurodegenerative diseases. A key approach for elucidating the pathogenic mechanisms is to probe the existence of oligomers directly in living cells. In this work, we were able to monitor the process of aggregation of Concanavalin A in live cells. We used number and brightness analysis, two-color cross number and brightness analysis, and Raster image correlation spectroscopy to obtain the number of molecules, aggregation state, and diffusion coefficient as a function of time and cell location. We observed that binding of Concanavalin A to the membrane and the formation of small aggregates paralle…

Time FactorsCell SurvivalCellSpectroscopy Imaging and Other TechniquesBiophysicsProtein aggregationCell morphologyCell membraneDiffusion03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineProtein structure2-NaphthylaminemedicineConcanavalin AAnimalsconfocal microscopy super resolution protein aggregation kinetics in live cells amyloid related pathologiesAnnexin A5Protein Structure QuaternaryCell Shape030304 developmental biology0303 health sciencesbiologySpectrum AnalysisCell MembraneFibroblastsEmbryo MammalianCell biologyMembranemedicine.anatomical_structurechemistryConcanavalin Abiology.proteinLaurdan030217 neurology & neurosurgeryFluorescein-5-isothiocyanateLaurates
researchProduct

Non-cross-linked collagen type I/III materials enhance cell proliferation: in vitro and in vivo evidence

2014

Objective: To analyze Mucograft®(MG), a recently introduced collagen matrix, in vitro and in vivo, and compare it with BioGide®(BG), a well-established collagen membrane, as control. Material and Methods: A detailed analysis of the materials surface and ultra-structure was performed. Cellular growth patterns and proliferation rates of human fibroblasts on MG and BG were analyzed in vitro. In addition, the early tissue reaction of CD-1 mouse to these materials was analyzed by means of histological and histomorphometrical analysis. Results: MG showed a three-fold higher thickness both in dry and wet conditions, when compared to BG. The spongy surface of BG significantly differed from that of …

Time FactorsCell SurvivalSurface PropertiesCellBiocompatible MaterialsMatrix (biology)BiologyPeripheral blood mononuclear cellCollagen Type IIIMiceRandom AllocationCollagen type IIn vivoMaterials TestingmedicineAnimalsHumansddc:610Bone regenerationGeneral DentistryCells CulturedCell ProliferationGuided tissue regenerationCell growthReproducibility of ResultsAnatomyOriginal ArticlesFibroblastsCollagen type IIIMolecular biologyImmunohistochemistryIn vitroBone regenerationlcsh:RK1-715medicine.anatomical_structurelcsh:DentistryFemaleCollagenJournal of Applied Oral Science
researchProduct

T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells

1977

THE control of herpes simplex virus (HSV) infection by immunological mechanisms seems to be complex and is poorly understood. Neutralising antibodies to HSV plus complement seem to have no effect on the propagation of HSV infection, because HSV spreads to adjacent cells by passing through intercellular bridges1–3. Anti-HSV antibodies plus complement, however, destroy virus-infected cells, but cannot prevent the spread of HSV, suggesting that the virus must be transferred to neighbouring cells before immune lysis occurs1,5. Therefore if lymphocyte-mediated cytolytic mechanisms are instrumental in blocking the spread of HSV in vivo, they ought to destroy infected cells at a very early stage i…

Time FactorsCell SurvivalT-Lymphocytesvirusesmedicine.disease_causeVirusMicrobiologyMiceImmune systemmedicineAnimalsSimplexvirusCytotoxic T cellCells CulturedAntibody-dependent cell-mediated cytotoxicityMultidisciplinarybiologyMacrophagesHerpes SimplexCytotoxicity Tests ImmunologicVirologyCTL*Herpes simplex virusMice Inbred CBAbiology.proteinAntibodyT cell mediated cytotoxicityNature
researchProduct